home / stock / abio / abio quote
Last: | $3.61 |
---|---|
Change Percent: | 2.11% |
Open: | $3.72 |
Close: | $3.61 |
High: | $3.96 |
Low: | $3.61 |
Volume: | 184,771 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.61 | $3.72 | $3.61 | $3.96 | $3.61 | 184,771 | 07-02-2024 |
$3.8 | $3.85 | $3.8 | $3.85 | $3.67 | 20,438 | 07-01-2024 |
$3.83 | $3.62 | $3.83 | $3.83 | $3.62 | 58,837 | 06-28-2024 |
$3.6 | $3.12 | $3.6 | $3.67 | $3.12 | 28,322 | 06-27-2024 |
$3.471 | $3.57 | $3.471 | $3.57 | $3.435 | 16,709 | 06-26-2024 |
$3.57 | $3.49 | $3.57 | $3.6 | $3.3601 | 32,356 | 06-25-2024 |
$3.49 | $3.41 | $3.49 | $3.6 | $3.41 | 33,233 | 06-24-2024 |
$3.5 | $3.29 | $3.5 | $3.55 | $3.1401 | 128,001 | 06-21-2024 |
$3.26 | $3.28 | $3.26 | $3.34 | $3.2001 | 27,934 | 06-20-2024 |
$3.34 | $3.29 | $3.34 | $3.34 | $3.105 | 153,303 | 06-19-2024 |
$3.34 | $3.29 | $3.34 | $3.34 | $3.105 | 153,303 | 06-18-2024 |
$3.22 | $3.26 | $3.22 | $3.34 | $3.2 | 24,957 | 06-17-2024 |
$3.31 | $3.31 | $3.31 | $3.31 | $3.11 | 30,836 | 06-14-2024 |
$3.32 | $3.33 | $3.32 | $3.35 | $3.3 | 16,662 | 06-13-2024 |
$3.34 | $3.23 | $3.34 | $3.42 | $3.23 | 32,114 | 06-12-2024 |
$3.28 | $3.2 | $3.28 | $3.3261 | $3.2 | 13,612 | 06-11-2024 |
$3.2 | $3.06 | $3.2 | $3.24 | $2.9001 | 124,738 | 06-10-2024 |
$3.28 | $3.29 | $3.28 | $3.4499 | $3.22 | 30,615 | 06-07-2024 |
$3.31 | $3.22 | $3.31 | $3.3436 | $3.21 | 70,287 | 06-06-2024 |
$3.31 | $3.46 | $3.31 | $3.5499 | $3.3 | 54,184 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / May 22, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Squarespace, Inc. (NYSE:SQSP)'s sale...
ARCA biopharma and Oruka Therapeutics announce Merger Agreement ARCA biopharma appoints Thomas Keuer as President WESTMINSTER, Colo., April 25, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), (the “Company”) a biopharmaceutical company app...